Cure My Disease

Don't miss your cure!

 Log in / Sign up

Door-to-Door help may increase COVID testing in Hard-to-Reach communities

NCT ID NCT05606016

Prevention Sponsor: The University of Texas Health Science Center, Houston Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This study tests whether community health workers can help increase COVID-19 testing among vulnerable adults. Participants receive either education and rapid antigen test kits or guidance on where to get tested. The goal is to see which approach leads to more people getting tested and using tests correctly.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Facilitated Self-Sampling Intervention (FSSI) and Testing Navigation Intervention (TNI) delivered by community health workers
What this could lead to
If effective, this approach could increase COVID-19 testing among vulnerable groups, helping to control spread and improve health equity.
What could go wrong
The study is early and focuses on a specific intervention; results may not apply broadly. Also, testing behavior can be influenced by many factors beyond the intervention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,232 people

The number who actually took part.

Started

Mar 2023

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older Exclusion Criteria: * Having been diagnosed with COVID-19 in the past 30 days based on a positive test (antigen or PCR) or a clinical diagnosis * Having tested for COVID-19 with PCR or antigen test within the past 30 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19

Contacts and locations

Locations

  • The University of Texas Health Science Center, Brownsville

    Brownsville, Texas, 78520, United States

  • The University of Texas Health Science Center, Houston

    Houston, Texas, 77030, United States

  • University of Texas Health Science Center,Tyler

    Tyler, Texas, 75708, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.